Logo

American Heart Association

  2
  0


Final ID: MDP1612

Opportunistic assessment of cardiovascular risk using deep learning of the heart and aorta on non-contrast chest computed tomography

Abstract Body (Do not enter title and authors here): Purpose Primary prevention of cardiovascular (CV) disease relies on accurate risk estimation. The coronary artery calcium score (CAC) can be measured on routine chest computed tomography (CT); however, it is unclear whether the heart and thoracic aorta regions on CT can provide additional information about future risk beyond calcium and risk factors.

Methods We applied the open-source TotalSegmentator tool to extract heart and thoracic aorta volumes from 27,943 non-contrast non-ECG gated chest CTs from 17,241 National Lung Screening Trial participants. We used the segmented volumes from 10,356 participants as input to train a new 3D Densenet169 deep learning model to predict 12-year CV mortality. Independent testing was performed in 5,165 individuals not used for model training with no history of type 2 diabetes, myocardial infarction, or stroke (eligible for primary prevention). The deep learning score was compared to a regression model using demographics, smoking, BMI, comorbidities, and the radiologist’s findings from the CT. We stratified the CAC and deep learning scores into high vs. low-risk groups using a CAC>100 and deep learning >10% risk threshold, respectively.

Results In the independent testing dataset, (N=5165; median age 60.0±8.0 years; 62.6% male), 3.3% died of CV disease. The deep learning score had higher discrimination for CV mortality than risk factors and CT findings (deep learning AUC 0.72 [0.68,0.76] vs. baseline AUC 0.66 [0.61,0.69], p < 0.001). Similar results were found for secondary outcomes of fatal myocardial infarction and fatal stroke. In a subset of 2,972 testing set individuals with measured CAC, those with high CAC and a high deep learning score had a 10.8% rate of 12-year CV mortality, higher than those with high CAC alone (4.1%, p<0.001).

Conclusion Based on the heart and thoracic aorta regions from CT, a deep learning model predicted 12-year CV mortality beyond prevalent risk factors, CAC, and imaging findings.

Clinical Relevance Opportunistic screening of chest CT using deep learning may enhance risk assessment to guide decisions for preventing CV events. External validation in population-representative cohorts is needed before clinical use.
  • Raghu, Vineet  ( Massachusetts General Hospital , Quincy , Massachusetts , United States )
  • Sturniolo, Audra  ( MGH , Boston , Massachusetts , United States )
  • Kiel, Douglas  ( Hebrew SeniorLife , Boston , Massachusetts , United States )
  • Aerts, Hugo  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Natarajan, Pradeep  ( Massachusetts General Hospital , Brookline , Massachusetts , United States )
  • Lu, Michael  ( Massachusetts General Hospital , Wellesley , Massachusetts , United States )
  • Author Disclosures:
    Vineet Raghu: DO NOT have relevant financial relationships | Audra Sturniolo: DO NOT have relevant financial relationships | Douglas Kiel: DO NOT have relevant financial relationships | Hugo Aerts: No Answer | Pradeep Natarajan: DO have relevant financial relationships ; Researcher:Allelica:Active (exists now) ; Advisor:Preciseli:Active (exists now) ; Advisor:MyOme:Active (exists now) ; Advisor:Esperion Therapeutics:Active (exists now) ; Advisor:TenSixteen Bio:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Genentech / Roche:Active (exists now) ; Consultant:Eli Lilly & Co:Active (exists now) ; Researcher:Novartis:Active (exists now) ; Researcher:Genentech / Roche:Active (exists now) | Michael Lu: DO have relevant financial relationships ; Research Funding (PI or named investigator):AstraZeneca:Past (completed) ; Research Funding (PI or named investigator):Risk Management Foundation of the Harvard Medical Institutions:Active (exists now) ; Research Funding (PI or named investigator):MedImmune:Past (completed) ; Research Funding (PI or named investigator):Kowa:Past (completed) ; Research Funding (PI or named investigator):Johnson & Johnson Innovation:Active (exists now) ; Research Funding (PI or named investigator):Ionis:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Know the Score: Cardiovascular Disease Risk Prediction

Monday, 11/18/2024 , 12:50PM - 02:15PM

Moderated Digital Poster Session

More abstracts on this topic:
Accuracy of Rule-based Natural Language Processing Models for Identification of Pulmonary Embolism

Rashedi Sina, Jimenez David, Monreal Manuel, Secemsky Eric, Klok Erik, Hunsaker Andetta, Aghayev Ayaz, Muriel Alfonso, Hussain Mohamad, Appah-sampong Abena, Aneja Sanjay, Krishnathasan Darsiya, Mojibian Hamid, Goldhaber Samuel, Wang Liqin, Zhou Li, Krumholz Harlan, Piazza Gregory, Bikdeli Behnood, Khairani Candrika, Bejjani Antoine, Lo Ying-chih, Zarghami Mehrdad, Mahajan Shiwani, Caraballo Cesar, Jimenez Ceja Jose Victor

A Two-year Longitudinal Investigation of Lipoprotein Particle Profile as Cardiometabolic Risk Biomarkers in Family Caregivers of Adult Patients with Cancer

Lee Lena, Shamburek Robert, Son Elisa H, Wallen Gwenyth, Yang Li, Tuason Ralph, Gerrard Chantal, Tsai Thomas, Kim Youngmee

More abstracts from these authors:
Opportunistic Screening for Cardiovascular Risk Using Chest X-Rays and Deep Learning: Associations with Coronary Artery Disease in the Project Baseline Health Study and Mass General Brigham Biobank

Chandra Jay, Lu Michael, Raghu Vineet, Karady Julia, Sturniolo Audra, Klop-packel Nory, Maron David, Rodriguez Fatima, Mahaffey Kenneth, Shah Svati

The Importance of Measuring Body Composition in Determining Cardiorespiratory Fitness Across the Adult Age Range

Gajjar Priya, Ravichandran Sandhiya, Sahni Shivani, Lewis Gregory, Kiel Douglas, Shah Ravi, Nayor Matthew

You have to be authorized to contact abstract author. Please, Login
Not Available